Axsome Therapeutics (NASDAQ:AXSM) Insider Sells $1,368,150.00 in Stock

Axsome Therapeutics insider Ari Maizel sold 7,500 shares of the company’s stock, valued at $1,368,150. This transaction reduced his position by 50%. The company recently reported better-than-expected EPS and revenue, but remains unprofitable, though analysts maintain a “Moderate Buy” rating with an average target price of $218.06.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin